DiabAccess project relies on the Sword Orizon solution to achieve comprehensive care of diabetic patients.


                            

In partnership with CERITD, Sword developed DiabAccess, a software allowing the follow-up and the management of the diabetic patients of the CERITD.

CERITD is a translational clinical research center dedicated to the application of telemedicine to the treatment of diabetes. It has developed a specific know-how, recognized and unique in France in the accompaniment of patients.

The key objectives of DiabAccess are:

  • Fluidify patient follow-up for the nurse,
  • Quick access to important patient information,
  • Monitor et facilitate exchange information between health professionals,
  • Facilitate orders/stock management organisation,
  • Manage nurse’s agenda and appointments with patients,
  • Analysis of statistical data and reports,
  • Facilitate mobility by providing offline access to patient records.
Dummy Data

More information on Sword Orizon

Latest news

Events

Sword Group | Outperformance & Acquisition in…

| Organic Growth for the 2nd quarter of 2021: 24.7%
| Acquisition in Switzerland
Read the following
Events

SFAF Meeting | Presentation of 2021 Half-Year Results

The 2021 SFAF Half-Year Results Presentation will be held on September 9th at 10:00 am, in Webcast. 

The meeting will be help in English and French.
Read the following
Events

Sword Group | New Win in BeLux

Read the following